OHB's Five-Day Slide Puts a €3.3 Billion Order Book on the Defensive

OHB SE shares fall to €197.80 amid sector-wide space selloff, but record €3.3B backlog and reaffirmed 2026 targets signal a correction, not a collapse.

The arithmetic is hard to argue with: a share price down 71 percent from its 52-week high, five consecutive losing sessions, and a valuation multiple that looks increasingly exposed. Yet the same company is sitting on a record order backlog of €3.304 billion and reaffirming its full-year guidance. That tension — between what the tape says and what the books show — is now the central question for anyone watching OHB SE.

The German space and technology group has spent the past week as the SDax's worst performer, with the stock sliding into the €200 neighborhood and slipping below its 200-day moving average. The trigger for the selling was a failed breakout attempt near €270, compounded by a sector-wide retreat that has dragged down space names from SpaceX to Rocket Lab. Analyst skepticism about the valuation has added fuel: at a price-to-earnings ratio of roughly 64, the shares were never going to be easy to defend once the group's momentum stalled.

A Correction, Not a Collapse

The distinction matters. The current price of €197.80 looks alarming next to the May peak, but that record was set during a bout of sector-wide euphoria following SpaceX's initial public offering. What began as collective enthusiasm has now become a collective unwinding — SpaceX itself has slipped below its own IPO price since mid-June. In that context, OHB's decline reads less like a repudiation of its operations and more like a repricing of an entire industry.

The fundamentals, at least on paper, support that interpretation. First-half results published in August showed total output of €628 million and adjusted EBITDA of €60 million, a gain of more than 30 percent year on year. Management has confirmed, not cut, its 2026 guidance for total output of €1.4 billion and an adjusted EBITDA margin between 10.5 and 11.0 percent. The order pipeline, meanwhile, reportedly encompasses around €20 billion in potential new projects.

There is also fresh business coming through the door. According to Handelsblatt, OHB has secured a major contract for 18 satellites under the EU's Iris2 program, worth roughly €1 billion and securing revenue into 2029. OHB Italia, for its part, landed an order from the Italian space agency ASI in late July for the second generation of the PRISMA mission, a project running through the end of 2031. The company's August entry into the SDax underscored its growing weight in the German small-cap segment.

Where the Skepticism Has Legs

None of this has been enough to halt the slide, and market participants point to a legitimate concern: the gap between a fat order book and the speed at which those orders convert into hard cash. Long project timelines are a structural feature of the space industry, not a quirk specific to OHB, but they do leave the stock vulnerable when sentiment turns. Positive headlines — the SDax inclusion, the Iris2 award — have produced only brief bounces before giving way to fresh selling, a pattern suggesting that buyers are not yet convinced.

The technical picture reinforces the caution. The shares trade roughly 27 percent below their 50-day average, a clear sign that the near-term trend remains firmly down. And the sector dependency cuts both ways: as long as SpaceX and its peers are struggling, OHB is likely to be dragged along regardless of its own order flow.

The Capital Raise Test

Complicating the picture is the capital increase completed just over two weeks ago, which raised €484 million. The free float rose to around 18 percent as a result, while the Fuchs family retains majority control with more than 60 percent of the shares. The move was designed to signal confidence — fresh money for growth, not for plugging holes. That the stock has kept falling regardless suggests the previous valuation had simply run too far ahead of the fundamentals, independent of the capital measure itself.

Several analysts published initial price targets for the stock in early August, ranging from €250 to €360 — comfortably above current levels. Whether those targets attract buyers depends on whether the sector-wide selling exhausts itself first.

What to Watch

The next concrete checkpoint is the third-quarter report, scheduled for November 12. If the guidance holds and the order book continues to grow, the current weakness would look increasingly like a valuation correction rather than an operational problem. The risk scenario is equally clear: any slippage in the guidance, whether from delays on Iris2, PRISMA, or other large projects, would validate the sellers and turn a technical correction into something more serious.

For now, OHB remains a stock for investors who can separate the noise of the tape from the substance of the balance sheet — and who are willing to wait for the market to make that distinction itself.